Skip to main content
Premium Trial:

Request an Annual Quote

Strand Genomics Expands Distribution Agreement with Canada s UBI: May 25, 2004 (rev. 2)

This article has been updated to include details on the expanded agreement.

 

NEW YORK, May 25 (GenomeWeb News) - Strand Genomics of Bangalore, India, has expanded its distribution agreement with Canada-based UBI for its Avadis software, the company said today.

 

Strandsaid that it originally signed a distribution agreement with UBI in late 2003 for its Acuris genome annotation software. The deal -- a non-exclusive distribution agreement for Canada-- was extended to include Avadis last month.

 

Avadis is a microarray gene expression analysis tool.

 

UBI, based in Calgary, specializes in distributing bioinformatics software.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.